Skip to main content
. 2020 Apr 24;11(4):273. doi: 10.1038/s41419-020-2478-0

Fig. 2. DDX11 is upregulated in HCC tissues and associated with poor prognosis.

Fig. 2

a Protein levels of DDX11 in 8 paired HCC and matched adjacent non-tumor tissues were determined by western blot assay. (N, matched adjacent non-tumor tissues; T, tumor tissues). b Representative expression pattern of DDX11 in HCC tissue samples. c Distribution of DDX11 immunohistochemical staining scores in HCC tissue samples according to TNM stage, histological grade, tumor size or vascular invasion. d, e Representative expression pattern of DDX11 in HCC tissue samples from patients with different TNM stages or in HCC tissue samples from patient with absent/present vascular invasion. f Univariate analysis of the association between DDX11 expression and clinicopathological features. g Kaplan–Meier analysis of the overall survival (OS) rate in HCC patients with high- or low- DDX11 expression in ZZU HCC cohort. *p < 0.05, **p < 0.01, ***p < 0.001.